Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Allogene Therapeutics Inc (NASDAQ: ALLO) was $2.70 for the day, up 3.45% from the previous closing price of $2.61. In other words, the price has increased by $3.45 from its previous closing price. On the day, 1.38 million shares were traded. ALLO stock price reached its highest trading level at $2.745 during the session, while it also had its lowest trading level at $2.64.
Ratios:
Our analysis of ALLO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.25 and its Current Ratio is at 12.25. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 21 ’24 when Douglas Earl Martin bought 28,310 shares for $2.79 per share.
MESSEMER DEBORAH M. sold 18,641 shares of ALLO for $42,488 on Jun 18 ’24. The Director now owns 166,765 shares after completing the transaction at $2.28 per share. On May 30 ’24, another insider, Humer Franz B, who serves as the Director of the company, sold 11,200 shares for $2.34 each. As a result, the insider received 26,181 and left with 255,253 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 564602432 and an Enterprise Value of 214183088. For the stock, the TTM Price-to-Sale (P/S) ratio is 6273.30 while its Price-to-Book (P/B) ratio in mrq is 1.10. Its current Enterprise Value per Revenue stands at 3295.125 whereas that against EBITDA is -0.835.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $5.78, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is 1.73%, while the 200-Day Moving Average is calculated to be -16.41%.
Shares Statistics:
ALLO traded an average of 2.16M shares per day over the past three months and 1773980 shares per day over the past ten days. A total of 167.13M shares are outstanding, with a floating share count of 136.57M. Insiders hold about 34.69% of the company’s shares, while institutions hold 66.85% stake in the company. Shares short for ALLO as of 1726185600 were 39187976 with a Short Ratio of 18.13, compared to 1723680000 on 39229292. Therefore, it implies a Short% of Shares Outstanding of 39187976 and a Short% of Float of 26.38.
